These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18453724)

  • 1. The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902.
    Lilienfeld DE
    Perspect Biol Med; 2008; 51(2):188-98. PubMed ID: 18453724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, supply, and suits--litigation and the vaccine industry.
    Kesselheim A
    N Engl J Med; 2011 Apr; 364(16):1485-7. PubMed ID: 21506740
    [No Abstract]   [Full Text] [Related]  

  • 5. Diphtheria serum and serotherapy. Development, production and regulation in fin de siècle Germany.
    Hüntelmann AC
    Dynamis; 2007; 27():107-31. PubMed ID: 18351161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Developments in the Regulation of Biologics.
    Coleman TS
    Food Drug Law J; 2016; 71(4):544-607. PubMed ID: 29140646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
    Noah L
    S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Brazilian pharmaceutical market and the North American war effort].
    Quintaneiro T
    Estud Hist; 2002; (29):141-64. PubMed ID: 18030707
    [No Abstract]   [Full Text] [Related]  

  • 9. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 10. The origin of the production of diphtheria antitoxin in France, between philanthropy and commerce.
    Simon J
    Dynamis; 2007; 27():63-82. PubMed ID: 18351159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The drug that launched a thousand sleds.
    Scheindlin S
    Mol Interv; 2008 Aug; 8(4):152-8. PubMed ID: 18829839
    [No Abstract]   [Full Text] [Related]  

  • 12. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT; Barash PG
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

  • 14. Food and Drug Administration regulation and evaluation of vaccines.
    Marshall V; Baylor NW
    Pediatrics; 2011 May; 127 Suppl 1():S23-30. PubMed ID: 21502242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paul Ehrlich and commercial serum production: on the control of diphtheria antitoxin in the laboratory and in industry].
    Hardy AI
    Medizinhist J; 2006; 41(1):51-84. PubMed ID: 16700300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rights, patents, markets and the global AIDS pandemic.
    Gathii JT
    Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139
    [No Abstract]   [Full Text] [Related]  

  • 17. The 1901 St Louis incident: the first modern medical disaster.
    DeHovitz RE
    Pediatrics; 2014 Jun; 133(6):964-5. PubMed ID: 24864186
    [No Abstract]   [Full Text] [Related]  

  • 18. The case for regulatory reform in the business and healthcare environments.
    Younis MZ; Barhem B; Hamidi S; Inungu J; Prater GS; O'Keefe A
    J Health Hum Serv Adm; 2009; 32(3):324-41. PubMed ID: 20099583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Stalinon scandal and its regulatory consequences, 1954-1959. Drug safety and therapeutic innovation in France fifty years back].
    Bonah C
    Rev Prat; 2007 Sep; 57(13):1501-5. PubMed ID: 18018550
    [No Abstract]   [Full Text] [Related]  

  • 20. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.